BLUEPRINT MEDICINES CORP shareholders Q3 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Truvestments Capital LLC 35$1,7580.00%
Tower Research Capital LLC (TRC) 933$46,8550.00%
PEAK6 Investments LLC 6,300$316,3860.00%
PEAK6 Investments LLC 4,895$245,8270.00%
D. E. Shaw & Co., Inc. 14,038$704,9880.00%
BLAIR WILLIAM & CO/IL 5,367$269,5310.00%
J.P. Morgan Private Wealth Advisors LLC 4,040$202,8890.00%
UBS Group AG 65,052$3,266,9110.00%
Citadel Advisors 52,000$2,611,4400.00%
Citadel Advisors 94,917$4,766,7320.00%
AMERIPRISE FINANCIAL INC 52,190$2,620,9820.00%
FARALLON CAPITAL MANAGEMENT LLC 4,000$200,8800.00%
UBS OCONNOR LLC 25,000$47,8750.00%
STRS OHIO 3,500$1750.00%
Invesco Ltd. 72,030$3,617,3460.00%
HARBOUR INVESTMENTS, INC. 200$10,0440.00%
NISA INVESTMENT ADVISORS, LLC 2,030$101,9470.00%
NOMURA HOLDINGS INC 10,500$527,3100.00%
WEST MICHIGAN ADVISORS, LLC 37$1,8580.00%
Legal & General Group Plc 58,456$2,935,6590.00%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q3 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.